Effects of oral gabapentin versus oral placebo on controlling of pain after central venous catheter insertion

Effects of oral gabapentin versus oral placebo on controlling of pain after central venous catheter insertion: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N535

Enrollment

Registered

2024-11-07

Start date

2024-11-10

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention group: Gabapentin tablets 1200 mg one hour before central venous catheter insertion and then 600 mg 3 times a day for a maximum of one week. Intervention 2: Control group:

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18 to 60 years Candidate for central venous catheter operation

Exclusion criteria

Exclusion criteria: Body mass index above 30 Treated with narcotic drugs Kidney or liver disorder Pregnancy

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: At 12, 24, 48 and 72 hours after central venous catheter insertion and also at the time of discharge. Method of measurement: Using Visual Analog Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSalman Shakiba

Hamedan University of Medical Sciences

bazvand_salman@yahoo.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026